Tirzepatide Tirzepatide, the active ingredient in the brand-name injectable GLP-1 medications Mounjaro and Zepbound, starts at 2.5 mg weekly and can be increased to 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg
Regular monitoring of B12 levels is crucial and healthcare providers can order periodic blood tests to track B12 levels, tailored to individual risk factors and health conditions
Let your care team know about any symptoms while taking this medicine
Using a fine needle, our providers inject PC/DC directly into the undersurface of the targeted fat through small punctures
Rapid or significant weight loss, a common effect of GLP-1 medications, can disrupt the hair growth cycle and contribute to increased shedding and hair thinning
however, our team is prepared to explore self-pay options and secured savings programs if needed